Literature DB >> 14688098

Biological activities of naturally occurring antibodies reactive with Candida albicans mannan.

Thomas R Kozel1, Randall S MacGill, Ann Percival, Qing Zhou.   

Abstract

Sera from normal adult humans may contain high levels of antibody reactive with Candida albicans mannan. This study examined selected biological activities of such antibodies, focusing on sera that were collected from 34 donors and analyzed individually. The results showed that antimannan titers were normally distributed. Reactivity as determined by enzyme-linked immunosorbent assay with serotype A mannan generally paralleled reactivity with serotype B. Analysis of the kinetics for activation of the complement system and deposition of complement component 3 (C3) onto serotype A and serotype B cells showed a decrease in the lag time that occurred before the onset of rapid accumulation of C3 that correlated with increasing antimannan titers. In contrast, there was a decrease in the overall rate of accumulation of C3 on serotype A cells that was strongly correlated with increasing antibody titers; serotype B cells showed no such decrease. An evaluation of the contribution of mannan antibody to opsonophagocytic killing showed that mannan antibody in individual sera and antimannan immunoglobulin G (IgG) affinity purified from human plasma contributed to killing by neutrophils in a dose-dependent fashion in the absence of a functional complement system. However, affinity-purified antibody in very high concentrations was inhibitory to both complement-dependent and complement-independent opsonophagocytosis, and this finding suggests a prozone-like effect. In contrast, if the complement system was functional, antimannan IgG was not needed for opsonophagocytic killing. These results suggest that naturally occurring mannan antibodies and the complement system are functionally redundant for opsonophagocytic killing by neutrophils.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688098      PMCID: PMC343987          DOI: 10.1128/IAI.72.1.209-218.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Serologic aspects on yeast classification.

Authors:  T Tsuchiya; Y Fukazawa; M Taguchi; T Nakase; T Shinoda
Journal:  Mycopathol Mycol Appl       Date:  1974-08-30

2.  In vitro studies of the interaction of murine phagocytic cells with Candida albicans.

Authors:  R P Morrison; J E Cutler
Journal:  J Reticuloendothel Soc       Date:  1981-01

3.  Kinetic analysis of the amplification phase for activation and binding of C3 to encapsulated and nonencapsulated Cryptococcus neoformans.

Authors:  T R Kozel; M A Wilson; W H Welch
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans.

Authors:  T R Kozel; L C Weinhold; D M Lupan
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  A comparison of specific IgG antibody levels to the cell wall mannan of Candida albicans in normal individuals and in patients with primary antibody deficiency.

Authors:  J A Faux; A E Agbarakwe; S A Misbah; H M Chapel
Journal:  J Immunol Methods       Date:  1992-08-30       Impact factor: 2.303

6.  Presence of human antibodies reacting with Candida albicans O-linked oligomannosides revealed by using an enzyme-linked immunosorbent assay and neoglycolipids.

Authors:  M P Hayette; G Strecker; C Faille; D Dive; D Camus; D W Mackenzie; D Poulain
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

7.  Structure of cell wall mannan of Candida kefyr IFO 0586.

Authors:  H Kobayashi; M Komido; M Watanabe; K Matsuda; M Suzuki; T Ikeda; H Oyamada; N Shibata; S Suzuki
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

8.  Requirement of heat-labile opsonins for maximal phagocytosis of Candida albicans.

Authors:  A Ferrante; Y H Thong
Journal:  Sabouraudia       Date:  1979-09

9.  Quantitation of antibody to Candida mannan by enzyme-linked immunosorbent assay.

Authors:  R A Greenfield; J L Stephens; M J Bussey; J M Jones
Journal:  J Lab Clin Med       Date:  1983-05

10.  Antibody response that protects against disseminated candidiasis.

Authors:  Y Han; J E Cutler
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more
  17 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 2.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

3.  Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Authors:  Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

4.  A fungicidal monoclonal antibody protects against murine invasive candidiasis.

Authors:  María J Sevilla; Beatriz Robledo; Aitor Rementeria; María D Moragues; José Pontón
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

5.  Large molecule specific assay operation: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.

Authors:  Lauren Stevenson; Marian Kelley; Boris Gorovits; Clare Kingsley; Heather Myler; Karolina Osterlund; Arumugam Muruganandam; Yoshiyuki Minamide; Mario Dominguez
Journal:  AAPS J       Date:  2013-11-16       Impact factor: 4.009

6.  Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.

Authors:  Mason X Zhang; M Charlotte Bohlman; Carol Itatani; Dennis R Burton; Paul W H I Parren; Stephen C St Jeor; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

7.  Detection of Candida albicans by culture, serology and PCR in clinical specimens from patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective.

Authors:  A Kalkanci; C Tuncer; B Degertekin; A Eren; S Kustimur; M N Ilhan; A Dursun
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

Review 8.  The protective role of immunoglobulins in fungal infections and inflammation.

Authors:  Sri Ramulu Elluru; Srini V Kaveri; Jagadeesh Bayry
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

9.  Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.

Authors:  Gayle M Boxx; Thomas R Kozel; Casey T Nishiya; Mason X Zhang
Journal:  Infect Immun       Date:  2009-12-22       Impact factor: 3.441

10.  The Cek1‑mediated MAP kinase pathway regulates exposure of α‑1,2 and β‑1,2‑mannosides in the cell wall of Candida albicans modulating immune recognition.

Authors:  E Román; I Correia; A Salazin; C Fradin; T Jouault; D Poulain; F-T Liu; J Pla
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.